ENTG Stock Analysis: Entegris | NASDAQ
Semiconductor Equipment & Materials | NASDAQ, USA | Market Cap: 25.414m USD | 12M Return: 72.1% | US29362U1043 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 297M
EPS Trend: 67.9%
Qual. Beats: 3
Rev. Trend: -68.0%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Entegris, Inc. (NASDAQ: ENTG) is a U.S.-based provider of advanced materials and process solutions serving the semiconductor industry and other high-technology manufacturing sectors. Founded in 1966 and headquartered in Billerica, Massachusetts, the company operates globally across North America, Taiwan, South Korea, Japan, China, Europe, and Southeast Asia. It is classified within the GICS Semiconductor Materials & Equipment sub-industry, a critical upstream segment of the chip supply chain that supplies consumables and equipment inputs to wafer fabs.
The company is organized into two reporting segments. The Materials Solutions (MS) segment supplies materials-based inputs such as chemical vapor deposition (CVD) and atomic layer deposition (ALD) precursors, chemical mechanical planarization (CMP) slurries and pads, ion implantation specialty gases, and formulated etch and clean chemistries. The Advanced Purity Solutions (APS) segment provides filtration, purification, and contamination-control products used throughout semiconductor manufacturing processes.
Entegris customer base spans the semiconductor value chain, including logic and memory device manufacturers, semiconductor equipment makers, gas and chemical suppliers, wafer growers, and outsourced semiconductor assembly and test (OSAT) facilities. Beyond semiconductors, the company also serves flat panel display equipment makers, hard disk drive component manufacturers, and customers in solar, life sciences, electrical discharge machining, glass, aerospace, and biomedical device manufacturing.
- AI chip demand lifts specialty deposition materials orders
- Taiwan and Korea fab expansions fuel Materials Solutions growth
- China export controls threaten Advanced Purity Solutions revenue
| Net Income: 305.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.72 > 1.0 |
| NWC/Revenue: 36.06% < 20% (prev 36.87%; Δ -0.80% < -1%) |
| CFO/TA 0.09 > 3% & CFO 780.7m > Net Income 305.5m |
| Net Debt (3.31b) to EBITDA (859.0m): 3.85 < 3 |
| Current Ratio: 3.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (153.6m) vs 12m ago 1.05% < -2% |
| Gross Margin: 45.48% > 18% (prev 44.09%; Δ 1.39% > 0.5%) |
| Asset Turnover: 39.44% > 50% (prev 38.15%; Δ 1.29% > 0%) |
| Interest Coverage Ratio: 2.79 > 6 (EBIT TTM 536.5m / Interest Expense TTM 192.1m) |
| A: 0.14 (Total Current Assets 1.78b - Total Current Liabilities 585.4m) / Total Assets 8.42b |
| B: 0.20 (Retained Earnings 1.71b / Total Assets 8.42b) |
| C: 0.06 (EBIT TTM 536.5m / Avg Total Assets 8.43b) |
| D: 0.98 (Book Value of Equity 4.16b / Total Liabilities 4.26b) |
| Altman-Z'' = 3.05 = A |
| DSRI: 1.10 (Receivables 559.1m/494.1m, Revenue 3.33b/3.22b) |
| GMI: 0.97 (GM 44.09% / 45.48%) |
| AQI: 0.98 (AQ_t 0.58 / AQ_t-1 0.59) |
| SGI: 1.03 (Revenue 3.33b / 3.22b) |
| TATA: -0.06 (NI 305.5m - CFO 780.7m) / TA 8.42b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of October 09, 2026, the stock is trading at USD 162.19 with a total of 2,648,320 shares traded. Over the past week, the price has changed by +2.34%, over one month by +14.95%, over three months by +17.02% and over the past year by +72.12%.
Current recommended Stop Loss: 153.40 (which is 5.4% or 1.4 ATR below the current price).
Entegris has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy ENTG.
- StrongBuy: 8
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 175.6 | 8.3% |
P/E Trailing = 83.5779
P/E Forward = 31.6456
P/S = 7.6407
P/B = 5.5488
P/EG = 1.3143
Revenue TTM = 3.33b USD
EBIT TTM = 536.5m USD
EBITDA TTM = 859.0m USD
Long Term Debt = 3.46b USD (from longTermDebt, last quarter)
Short Term Debt = 15.8m USD (from shortTermDebt, last fiscal year)
Debt = 3.66b USD (from shortLongTermDebtTotal, last quarter) + Leases 104.0m
Net Debt = 3.31b USD (calculated: Debt 3.66b - CCE 353.6m)
Enterprise Value = 28.7b USD (25.4b + Debt 3.66b - CCE 353.6m)
Interest Coverage Ratio = 2.79 (Ebit TTM 536.5m / Interest Expense TTM 192.1m)
EV/FCF = 49.94x (Enterprise Value 28.7b / FCF TTM 575.2m)
FCF Yield = 2.00% (FCF TTM 575.2m / Enterprise Value 28.7b)
FCF Margin = 17.29% (FCF TTM 575.2m / Revenue TTM 3.33b)
Net Margin = 9.18% (Net Income TTM 305.5m / Revenue TTM 3.33b)
Gross Margin = 45.48% ((Revenue TTM 3.33b - Cost of Revenue TTM 1.81b) / Revenue TTM)
Gross Margin QoQ = 47.55% (prev 46.90%)
Tobins Q-Ratio = 3.41 (Enterprise Value 28.7b / Total Assets 8.42b)
Interest Expense / Debt = 5.24% (Interest Expense 192.1m / Debt 3.66b)
Taxrate = 7.42% (24.5m / 330.3m)
NOPAT = 496.7m (EBIT 536.5m * (1 - 7.42%))
Current Ratio = 3.05 (Total Current Assets 1.78b / Total Current Liabilities 585.4m)
Debt / Equity = 0.88 (Debt 3.66b / totalStockholderEquity, last quarter 4.16b)
Debt / EBITDA = 3.85 (Net Debt 3.31b / EBITDA 859.0m)
Debt / FCF = 5.76 (Net Debt 3.31b / FCF TTM 575.2m)
Total Stockholder Equity = 4.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.62% (Net Income 305.5m / Total Assets 8.42b)
RoE = 7.61% (Net Income TTM 305.5m / Total Stockholder Equity 4.01b)
RoCE = 7.18% (EBIT 536.5m / Capital Employed (Equity 4.01b + L.T.Debt 3.46b))
RoIC = 6.47% (NOPAT 496.7m / Invested Capital 7.68b)
WACC = 14.87% (E(25.4b)/V(29.1b) * Re(16.31%) + D(3.66b)/V(29.1b) * Rd(5.24%) * (1-Tc(0.07)))
Discount Rate = 16.31% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 89.13 | Cagr: 0.55%
[DCF] Terminal Value 59.80% ; FCFF base≈450.3m ; Y1≈516.2m ; Y5≈759.7m
[DCF] Fair Price = 12.80 (EV 5.27b - Net Debt 3.31b = Equity 1.96b / Shares 152.8m; r=14.87% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 67.93 | EPS CAGR: 4.34% | SUE: 2.42 | # QB: 3
Revenue Correlation: -67.99 | Revenue CAGR: -3.12% | SUE: 2.53 | # QB: 1
EPS current Quarter (2026-09-30): EPS=1.02 | Chg30d=+0.18% | Revisions=+75% | Analysts=12
EPS current Year (2026-12-31): EPS=3.92 | Chg30d=+0.08% | Revisions=+62% | GrowthEPS=+42.7% | GrowthRev=+11.8%
EPS next Year (2027-12-31): EPS=5.03 | Chg30d=+0.28% | Revisions=+79% | GrowthEPS=+28.2% | GrowthRev=+12.8%
[Analyst] Revisions Ratio: +85% (up=29, down=1)